The Steroidogenesis Inhibitor Finasteride Reduces the Response to Both Stressful and Rewarding Stimuli
Finasteride (FIN) is the prototypical inhibitor of steroid 5α-reductase (5αR), the enzyme that catalyzes the rate-limiting step of the conversion of progesterone and testosterone into their main neuroactive metabolites. FIN is clinically approved for the treatment of benign prostat...
Main Authors: | Sean C. Godar, Roberto Cadeddu, Gabriele Floris, Laura J. Mosher, Zhen Mi, David P. Jarmolowicz, Simona Scheggi, Alicia A. Walf, Carolyn J. Koonce, Cheryl A. Frye, Nancy A. Muma, Marco Bortolato |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/9/11/749 |
Similar Items
-
Finasteride adverse effects and post-finasteride syndrome; implications for dentists
by: Stana Paunica, et al.
Published: (2016-04-01) -
Combination of finasteride and flutamide as potency-sparing hormone ablation therapy in management of advanced carcinoma of prostate
by: N K Mohanty, et al.
Published: (2001-01-01) -
Finasteride Side Effects and Post-Finasteride Syndrome in Male Androgenic Alopecia
by: Manea Mirela, et al.
Published: (2015-10-01) -
Post-finasteride syndrome: An emerging clinical problem
by: Silvia Diviccaro, et al.
Published: (2020-05-01) -
A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
by: Tony Antoniou, et al.
Published: (2018-05-01)